CA2252739A1 - Opto-acoustic thrombolysis - Google Patents

Opto-acoustic thrombolysis Download PDF

Info

Publication number
CA2252739A1
CA2252739A1 CA002252739A CA2252739A CA2252739A1 CA 2252739 A1 CA2252739 A1 CA 2252739A1 CA 002252739 A CA002252739 A CA 002252739A CA 2252739 A CA2252739 A CA 2252739A CA 2252739 A1 CA2252739 A1 CA 2252739A1
Authority
CA
Canada
Prior art keywords
fiber optic
laser light
ambient medium
liquid ambient
laser
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002252739A
Other languages
French (fr)
Inventor
Peter Celliers
Luiz Da Silva
Michael Glinsky
Richard London
Duncan Maitland
Dennis Matthews
Joseph P. Fitch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2252739A1 publication Critical patent/CA2252739A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/22Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
    • A61B18/26Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor for producing a shock wave, e.g. laser lithotripsy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B17/22004Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves
    • A61B17/22012Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement
    • A61B17/2202Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement the ultrasound transducer being inside patient's body at the distal end of the catheter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017Electrical control of surgical instruments
    • A61B2017/00022Sensing or detecting at the treatment site
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B2017/22082Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for after introduction of a substance
    • A61B2017/22084Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for after introduction of a substance stone- or thrombus-dissolving
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/36Image-producing devices or illumination devices not otherwise provided for
    • A61B90/37Surgical systems with images on a monitor during operation
    • A61B2090/378Surgical systems with images on a monitor during operation using ultrasound

Abstract

This invention is a catheter-based device for generating an ultrasound excitation in biological tissue. Pulsed laser light is guided through an optical fiber (10) to provide the energy for producing the acoustic vibrations. The optical energy is deposited in a water-based absorbing fluid, e.g. saline, thrombolytic agent, blood or thrombus, and generates an acoustic impulse in the fluid through thermoelastic and/or thermodynamic mechanisms. By pulsing the laser at a repetition rate (which may vary from 10 Hz to 100 kHz) an ultrasonic radiation field can be established locally in the medium. This method of producing ultrasonic vibrations can be used in vivo for the treatment of stroke-related conditions in humans, particularly for dissolving thrombus or treating vaspasm. The catheter (14) can also incorporate thrombolytic drug treatments as an adjunct therapy and it can be operated in conjunction with ultrasonic detection equipment for imaging and feedback control and with optical sensors for characterization of thrombus type and consistency.

Description

CA 022~2739 l998-l0-26 W 0 97/39690 PCT~US97/06861 OPTO-ACOUSTIC THROMBOIJYSIS

The United States Government has rights in this invention pursuant to Contract No. W-7405-ENG-48 between the United States Department of Energy and the University of California for the operation of Lawrence Livermore National Laboratory.
BACKGROUND OF THE INVENTION
Field of the Invention The present invention is directed to the removal of blockages in tubular tissues and organs, and more specifically, it relates to the removal of intravascular occlusions such as atherosclerotic plaque or thrombus.
Description of Related Art Ischemic strokes are caused by the formation or lodging of thrombus in the arterial network supplying the brain. Typically these occlusions are found in the carotid artery or even smaller vessels located still higher in the cranial cavity. Interventional cardiologists and vascular surgeons have devised minimally invasive procedures for treating these conditions in the vasculature elsewhere in the body.
Among these treatments is ultrasound angioplasty whereby a microcatheter is directed to the site of an occlusion. An ultrasonic transducer is coupled to a transmission medium that passes within the catheter and transmits vibrations to a working tip at the distal end in close proximity to the occlusion. Ultrasonic catheters for dissolving atherosclerotic plaque and for facilitating clot lysis have been described previously. Improvements on these inventions have concentrated on improving the operation or function of the same basic device (Pflueger et al., U.S. Patent No. 5,397,301). The vi~rations coupled into the tissues help to dissolve or emulsify the clot through various ultrasonic mechanisms such as cavitation bubbles and microjets which expose the CA 022~2739 1998-10-26 .
W ~ 97/39690 PCTAJS97/06861 clot to strong localized shear and tensile stresses. These prior art devices are usually operated in conjunction with a thrombolytic drug and/or a radiographic contrast agent to facilitate visualization.
The ultrasonic catheter devices all have a common configuration in which the source of the vibrations (the transducer) is external to the catheter. The vibrational energy is coupled into the proximal end of the catheter and transmitted down the length of the catheter through a wire that can transmit the sound waves. There are associated disadvantages with this configuration: loss of energy through bends and curves with concomitant heating of the tissues in proximity;
the devices are not small enough to be used for treatment of stroke and are difficult to scale to smaller sizes; it is difficult to assess or control dosimetry because of the unknown and varying coupling efficiency between the ultrasound generator and the distal end of the catheter.
Dubrul et al., U.S. Patent No. 5,380,273, attempts to improve on the prior art devices by incorporating advanced materials into the transmission member. Placement of the ultrasonic transducer itself at the distal end of the catheter has been impractical for a number of reasons including size constraints and power requirements.
A related method for removing occlusions is laser angioplasty in which laser light is directed down an optical fiber to impinge directly on the occluding material. Laser angioplasty devices have been found to cause damage or destruction of the surrounding tissues. In some cases uncontrolled heating has lead to vessel perforation. The use of high energy laser pulses at a low or moderate repetition rate, e.g. around 1 Hz to 100 Hz, results in non-discriminatory stress waves that significantly damage healthy tissue and/or result in insufficient target-tissue removal when the independent laser parameters are adjusted such that healthy tissue is not affected. Use of high energy laser light to avoid thermal heating has been found to cause damage through other mechanisms associated with large cavitation bubbles and shock waves that puncture or otherwise adversely affect the tissue.

. . .

CA 022~2739 l998-l0-26 W ~ 97/39690 PCTrUS97/06861 SUMMARY OF TH~ INVENTION
It is an object of the present invention to provide means for dissolution of a vascular occlusion with a high frequency train of low energy laser pulses which generate ultrasonic excitation in the fluids in close proximity to the occlusion.
Energy transmission through a catheter is provided by using an optical fiber to guide laser pulses to the distal end. However, unlike laser angioplasty or laser thrombolysis, the present invention does not rely on direct ablation of the occlusion, but instead uses a high frequency train of low energy laser pulses to generate ultrasonic excitations in the fluids in close proximity to the occlusion. Dissolution of the occlusion is then prompted by ultrasonic action and/or by emulsification, and not directly by the interaction with the laser light.
The key to inducing an ultrasonic response in the tissues and fluids lies in careful control of the wavelength, pulse duration, pulse energy and repetition rate of the laser light. The use of optical energy to induce an ultrasonic excitation in the tissue offers a number of advantages. Optical fibers can be fabricated to small dimensions, yet are highly transparent and capable of delivering substantial optical power densities from the source to the delivery site with little or no attenuation. Optical fibers are also flexible enough to navigate all vessels of interest. The present invention allows delivery of sufficient energy to generate the acoustic excitation through a small and flexible catheter, such as is required for stroke treatment. The method may also incorporate a feedback mechanism for monitoring and controlling the magnitude of the acoustic vibrations induced in the tissue.
BRIEF DESCRIPTION OF T~ DRAWINGS
Figure lA shows a sketch of an application of the optical fiber-based opto-acoustic thrombolysis catheter of the present invention.
Figure lB depicts the ultrasonic dissolution of a blockage using an adjunct fluid.
Figures 2A-C depict the thermo-elastic operation of the present invention.

CA 022~2739 1998-10-26 W O 97/39690 PCT~US97/06861 Figures 3A-C depict the superheated vapor expansion mode of the present invention.
Figure 4A shows a fiber optic having a concave tip.
Figure 4B shows a fiber optic having a convex tip.
Figure 5 shows a bundle of fiber strands.
Figure 6 shows a variable diameter fiber optic.
Figure 7 shows a composite of a glass/plastic fiber.
DETAILED DESCRIPTION OF THE INVENTION
The invention incorporates a catheter containing an optical fiber. The optical fiber is coupled at the proximal end to a high repetition rate laser system which injects pulses of light into the fiber.
The light emerging from the fiber at the distal end is absorbed by the fluid surrounding the catheter. This fluid may be blood, a biological saline solution containing an absorbing dye, a thrombolytic pharmaceutical or thrombus itself. The optical fiber functions as a means of energy transmission such that the optical energy produced by the laser is delivered to the end of the fiber. The laser light emerging from the distal end of the fiber optic has a pulse frequency within the range of 10 Hz to 100 kHz, a wavelength within the range of 200 nm to 5000 nm and an energy density within the range of 0.01 J/cm2 to 4 J/cm2, or up to 50 ~/cm2, if dictated by a small optical fiber diameter. The energy applied is maintained below 5 milli-Joules, and preferably less than one milliloule. In one embodiment, the pulse frequency is within the range of 5 kHz to 25 kHz. Alternately, a lower end of the pulse frequency range may be 100, 200, 400 or 800 Hz, with an upper end of the range being 25, 50 or 100 kHz.
Lysis of thrombus, atherosclerotic plaque or any other occluding material in the tubular tissue is facilitated by an ultrasonic radiation field created in the fluids near the occlusion. As an adjunct treatment, a working channel which surrounds or runs parallel to the optical fiber may be used to dispense small quantities of thrombolytic drugs to facilitate further lysis of any significantly sized debris (>511m dia.
particles) left over from the acoustic thrombolysis process. The conversion of optical to acoustic energy may proceed through several CA 022~2739 1998-10-26 W O 97/39690 PCTrUS97/06861 mechanisms that may be thermoelastic, thermodynamic or a combination of these. Figure lA shows an optical fiber 10 with a parallel working channel 12, where both the fiber 10 and the working channel 12 are both located within a catheter 14 which has been inserted into a 5 blood vessel 16. The distal end of fiber 10 is placed near thrombus 18 and stenotic plaque 20 within blood vessel 16. In Figure lB, fiber 10 delivers laser light to produce a collapsing cavitation bubble 11 and the resulting expanding acoustic wave 13. A parallel working channel 12 in catheter 14 delivers an adjunct fluid 15 to aid in the removal of occlusion 17 10 from inside blood vessel 16.
As depicted in Figures 2A-C, in the thermoelastic mode, trough fiber optic 21, each laser pulse 22 delivers a controlled level of energy in the fluid 24 which creates a large thermoelastic stress in a small volume of the fluid. The expanding direction of this stress is indicated by arrows 25 in figure 2A. The volume of fluid 24 which is heated by the laser pulse 22 is determined by the absorption depth of the laser light in the fluid 24, and must be controlled to produce a desired size. For example, an appropriate size may be the fiber diameter, or a distance comparable to some fraction of the vessel containing the 20 occlusion. This can be adjusted by controlling the laser wavelength or the composition of the fluid such that most of the laser energy is deposited in a fluid depth of the desired size. The laser pulse duration is short enough to deposit all of the laser energy into the absorbing fluid in a time scale shorter than the acoustic transit time across the smallest 25 dimension of absorbing region. This is an isochoric (constant volume) heating process. For an absorption volume of approximately 100,um in diameter the acoustic transit time is approximately 70 ns, so the deposition time must be significantly less than this, e.g., around 10 ns.
The absorbing fluid responds thermoelastically to the 30 deposition of energy such that a region of high pressure is created in the fluid in the heated volume. The boundary of the high pressure zone decays into a pattern of acoustic waves: a compression wave propagates away from the energy deposition region (diverging wave front) and a rarefaction wave propagates towards the center of the energy deposition CA 022~2739 1998-10-26 W O 97/39690 PCT~US97/06861 region (converging wave front). When the rarefaction wave converges on the center of the initial deposition region, it creates a region 26 of tensile stress that promotes the formation of a cloud of cavitation bubbles which coalesce to form a larger bubble 30. Eventually, the 5 cavitation bubble collapses (32), resulting in an expanding acoustic wave 33. Collapse and subsequent rebound of the cavitation bubble will generate acoustic impulses in the surrounding fluid, which will carry off a portion of the energy of the cavity. The collapse and rebound processes take place on a time scale governed principally by the fluid density and 10 the maximum size of the initial cavity. The first collapse and rebound will be followed by subsequent collapse and rebound events of diminishing intensity until the energy of the cavity is dissipated in the fluid. Subsequent laser pulses are delivered to repeat or continue this cycle and generate an ultrasonic radiation field at a frequency or 15 frequencies determined by the laser pulse frequency.
To summarize, a device operating through the first mode produces an ultrasonic radiation field in the fluid by: (i) depositing laser energy in a volume of fluid comparable to the fiber dimension in a time scale of duration less than the acoustic transit time across this 20 dimension (as controlled by choice of laser wavelength and absorbing fluid as the case may be); (ii) controlling the laser energy such that the maximum size of the cavitation bubble is approximately the same as that the fiber diameter; and (iii) pulsing the laser at a repetition rate such that multiple cycles of this process generates an acoustic radiation field 25 in the surrounding fluid; resonant operation may be achieved by synchronizing the laser pulse repetition rate with the cavity lifetime.
Typical operation leads to a fluid-based transducer that cycles at 1 - 100 kHz with a reciprocating displacement of 100-200 ~lm (for typical optical fiber dimensions). This displacement is very similar to that found in 30 mechanically-activated ultrasound angioplasty devices.
In the superheated vapor expansion mode, as shown in Figures 3A-C, in fiber optic 41, each laser pulse 40 delivers a controlled level of energy in the fluid within an absorption depth which is very small compared to the characteristic size of the vessel containing the . .

CA 022~2739 1998-10-26 .

catheter, or even small compared to the fiber diameter. The absorption depth may also be small compared to the distance that a sound wave travels in the duration of the laser pulse. The laser energy deposits a sufficient level of energy to heat all of the fluid within the absorption 5 depth well above the vaporization temperature of the fluid at the ambient pressure. In the process of depositing the laser energy, a thermoelastically-generated acoustic wave is launched in the fluid, which propagates out from the heated region. On time scales longer than 1 lls, the superheated fluid 42 undergoes vaporization, which 10 creates a bubble of vapor. As the fluid vaporizes, its volume 44 increases by a large factor, hence the need for involving only a small layer of fluid such that the ultimate size of the vapor bubble does not exceed, for example, the vessel diameter The laser pulse duration need not be restricted to times as 15 short as in the thermoelastic mode since the bubble expansion is nearly an isobaric process; however, the laser pulse duration should be shorter than the bubble expansion time, and it should be much shorter than a typical thermal relaxation time for the superheated region. (According to the Rayleigh bubble collapse theory the bubble lifetime is 20 approximately 25 lls for a 50 llm diameter bubble; thermal relaxation occurs on a few hundred microsecond time scale, so the laser pulse should be several microseconds or less in duration). The vapor bubble expands up to a maximum radius which depends on the vapor pressure initially created in the fluid. At the maximum bubble radius, the vapor 25 pressure in the expanded bubble has dropped to well below the ambient pressure and the bubble 46 undergoes collapse, resulting in an expanding acoustic wave 48. Rebound and subsequent collapse events may take place following the first collapse. The bubble expansion and collapse couples acoustic energy into the fluid. Subsequent laser pulses are 30 delivered to repeat or continue this cycle and generate an ultrasonic radiation field at a frequency or frequencies determined by the laser pulse frequency. Similar to the first mode, a resonant operation may be achieved by matching the laser pulse period to the lifetime of the cavitation bubble.

CA 022~2739 1998-10-26 W ~ 97/39690 PCT~US97/06861 To summarize, a device operating through the second mode produces an ultrasonic radiation field in the fluid by: (i) depositing laser energy in a small volume of fluid (as controlled by choice of laser wavelength and absorbing fluid as the case may be); (ii) controlling the 5 laser energy such that the maximum size of the cavitation bubble is approximately the same as the fiber diameter; and (iii) pulsing the laser energy at a repetition rate such that multiple cycles of the bubble generation and collapse process generates an acoustic radiation field in the surrounding fluid. Unlike the first mode, the delivery time is not a 10 significant issue, so longer pulse duration lasers (up to several ~lS) may be useful.
For either mode of operation the laser wavelength, laser pulse duration and laser absorption depth must be precisely controlled such that an adequate acoustic response is obtained with a minimum of 15 laser pulse energy. For the first mode this entails matching the absorption volume to a characteristic dimension of the system such as the fiber diameter or some fraction of the vessel diameter, and using a short laser pulse (less than 20 ns). For second mode this entails depositing the laser energy in a very small absorption depth to achieve a 20 sufficient level of superheat in a small fluid mass such as can be accommodated by a small energy budget and without creating a vapor bubble so large as to be damaging to the surrounding tissues.
These opto-acoustic modes of coupling laser energy into acoustic excitations in tissues include a number of features. Low to 25 moderate laser pulse energy combined with high repetition rate avoids excessive tissue heating or intense shock generation. Localized absorption of the laser energy occurs. Laser energy may interact thermoelastically or thermodynamically with the ambient fluids. An acoustic radiation field is generated by repeated expansion and collapse 30 of a small cavitation bubble at the tip of the fiber. Resonant operation may be achieved by matching the laser pulse period to the cavitation lifetime. Soft fibrous occlusions (thrombus) may be dissolved by generating the cavitation bubbles directly within the thrombus.

CA 022~2739 1998-10-26 W O 97/39690 PCTrUS97/06861 Control and/or manipulation of the spatial and temporal distribution of energy deposited in the fluid at the fiber tip can be used modify the near field acoustic radiation pattern, for example, to concentrate acoustic energy on an object in proximity to the fiber, or to distribute the acoustic radiation more uniformly. Techniques based on this strategy will be most successful for a special case of thermoelastic response (first mode) where the laser pulse duration is short and the fluid absorption is also relatively strong, such that the laser energy is deposited in a thin layer adjacent to the surface of the fiber tip. For example, by forming a concave surface on the fiber tip, the optical energy is deposited in the fluid in a similar shaped distribution. Acoustic waves emitted from this concave distribution will tend to focus to a point at a distance R from the fiber tip, where R is the radius of curvature of the concave surface. A planar fiber tip will generate an initially planar acoustic wavefront in proximity the fiber tip. A convex fiber tip will produce a diverging spherical wavefront which will disperse the acoustic energy over a larger solid angle. Another means of modifying the near field radiation pattern may be to use a fiber bundle through which the laser energy is delivered, and control the temporal distribution of deposited laser energy. The laser energy may be arranged to arrive at individual fiber strands in the catheter tip at different times, which, in combination with the different spatial positions of these individual strands, can be adjusted to control the directionality and shape of the acoustic radiation pattern, similar to phased-array techniques used in radar. Figure 4A shows a modified fiber optic 50 having a concave distal end 52. Figure 4B shows a fiber optic 50 with a convex distal end 54. Figure 5 shows a modified fiber optic 56 consisting of a bundle of fiber strands 58, through each of which laser pulse energy is delivered at varying times.
Commercial fibers are usually jacketed to protect them from the environment. "Bare" or unjacketed fibers are available. It is helpful to use coatings on fibers to make them slide more easily through catheters. As shown in Figure 6, a variable diameter optical fiber 60 allows for greater physical strength at the proximal end 62 and greater CA 022~2739 1998-10-26 WO 97/39690 PCT/US97tO6861 access at the distal end 64. This can be accomplished through modifying existing fibers (stripping the protective sheath from around the core) or by making custom fibers. Custom fabrication can be accomplished by varying the extrusion or draw rate for the fiber. Glass or plastic 5 composition can be changed as a function of drawing the fiber so that greater control of the fiber from a distal end is achieved without sacrificing optical quality. One particular instance of this is to treat the tip so that it is "soft," so the end will not jam in the catheter sheath.
Also, shape memory in the tip allows steering of the fiber when it 10 protrudes from the distal end of the catheter sheath.
Figure 7 shows a composite of a glass/plastic fiber. Fiber 70 comprises a glass portion 72 with a relatively short plastic tip 74 which has a length within the range of a millimeter to a several centimeters.
Due to the rigidity of the glass portion 72, a fiber optic having this 15 configuration is easily pushed through vasculature. The softer plastic tip 74 is less likely to puncture a vein wall than a glass tip. This configuration could include an additional glass tip to increase the durability of the fiber optic.
Acoustic energy at many frequencies is generated in the 20 present invention, and may be considered as a signal source for producing acoustic images of structures in body tissues. Any signal detection and analysis system which relies on a point source of acoustic radiation to produce the signal may be used with this invention.
Applications envisioned for this invention include any 25 method or procedure whereby localized ultrasonic excitations are to be produced in the body's tissues through application of a catheter. The invention may be used in (i) endovascular treatment of vascular occlusions that lead to ischemic stroke (This technology can lyse thrombus and lead to reperfusion of the affected cerebral tissue), (ii) 30 endovascular treatment of cerebral vasospasm (This technology can relax vaso-constriction leading to restoration of normal perfusion and therefore prevent further transient ischemic attacks or other abnormal perfusion situations), (iii) endovascular treatment of cardiovascular occlusions (This technology can lyse thrombus or remove CA 022~2739 l998-l0-26 W O 97/39690 PCT~US97/06861 -atherosclerotic plaque from arteries), (iv) endovascular treatment of stenoses of the carotid arteries, (v) endovascular treatment of stenoses of peripheral arteries, (vi) general restoration of patency in any of the body's luminal passageways wherein access can be facilitated via percutaneous insertion, (vii) any ultrasonic imaging application where a localized (point) source of ultrasonic excitation is needed within an organ or tissue location accessible through insertion of a catheter, (viii) lithotriptic applications including therapeutic removal of gallstones, kidney stones or other calcified objects in the body and (ix) as a source of ultrasound in ultrasound modulated optical tomography.
The pulsed laser energy source used by this invention can be based on a gaseous, liquid or solid state medium. Rare earth-doped solid state lasers, ruby lasers, alexandrite lasers, Nd:YAG lasers and Ho:YLF lasers are all examples of lasers that can be operated in a pulsed mode at high repetition rate and used in the present invention. Any of these solid state lasers may incorporate non-linear frequency-doubling or frequency-tripling crystals to produce harmonics of the fundamental lasing wavelength. A solid state laser producing a coherent beam of ultraviolet radiation may be employed directly with the invention or used in conjunction with a dye laser to produce an output beam which is tunable over a wide portion of the ultraviolet and visible spectrum.
Tunability over a wide spectrum provides a broad range of flexibility for matching the laser wavelength to the absorption characteristics of the fluids located at the distal end of the catheter. The output beam is coupled by an optical fiber to the surgical site through, for example, a percutaneous catheter. In operation, a pulsed beam of light drives the ultrasonic excitation which removes and/or emulsifies thrombus or atherosclerotic plaque with less damage to the underlying tissue and less chance of perforating the blood vessel wall than prior art devices.
Various other pulsed lasers can be substituted for the disclosed laser sources. Similarly, various dye materials and configurations can be used in the dye laser. Configurations other than a free-flowing dye, such as dye-impregnated plastic films or cuvette-encased dyes, can be substituted in the dye laser. The dye laser can also CA 022~2739 1998-10-26 W O 97/39690 PCTrUS97/06861 store a plurality of different dyes and substitute one for another automatically in response to user-initiated control signals or conditions encountered during use (e.g. when switching from a blood-filled field to a saline field or in response to calcific deposits). Suitable dyes for use in 5 the dye laser components of the invention include, for example, P-terphenyl (peak wavelength 339); BiBuQ (peak wavelength: 385); DPS
(peak wavelength: 405); and Coumarin 2 (peak wavelength: 448).
In yet another embodiment the pulsed light source may be an optical parametric oscillator (OPO) pumped by a frequency-doubled or 10 frequency-tripled solid-state laser. OPO systems allow for a wide range of wavelength tunability in a compact system comprised entirely of solid state optical elements. The laser wavelength in OPO systems may also be varied automatically in response to user-initiated control signals or conditions encountered during use.
Catheters, useful in practicing the present invention, can take various forms. For example, one embodiment can consist of a catheter having an outer diameter of 3.5 millimeters or less, preferably 2.5 millimeters or less. Disposed within the catheter is the optical fiber which can be a 400 micron diameter or smaller silica (fused quartz) fiber such as the model SG 800 fiber manufactured by Spectran, Inc. of Sturbridge, Mass. The catheter may be multi-lumen to provide flushing and suction ports. In one embodiment the catheter tip can be constructed of radio-opaque and heat resistant material. The radio-opaque tip can be used to locate the catheter under fluoroscopy.
The invention can be used with various catheter devices, including devices which operate under fluoroscopic guidance as well as devices which incorporate imaging systems, such as echographic or photoacoustic imaging systems or optical viewing systems. For one example of a photoacoustic imaging system which can be specifically adapted for the catheter environment, see U.S. Pat. No. 4,504,727 incorporated herein by reference.
Changes and modifications in the specifically described embodiments can be carried out without departing from the scope of the invention, which is intended to be limited by the scope of the appended clalms.

.

Claims (48)

-14-
1. A method for delivering acoustic energy into the cerebrovasculature during percutaneous transluminal access procedures, comprising:
inserting a fiber optic into the vasculature to a point near an occlusion, wherein said fiber optic comprises a proximal end and a distal end; and coupling laser light into said proximal end, wherein said laser light has (i) a pulse frequency within the range of 5 kHz to 25 kHz, (ii) a wavelength within the range of 200 nm to 5000 nm and (iii) an energy density within the range of 0.01 J/cm2 to 4 J/cm2, wherein said laser light emerges from said distal end to generate an acoustic radiation field in a liquid ambient medium, wherein said acoustic radiation field is generated through a mechanism selected from a group consisting of thermoelastic expansion within said liquid ambient medium and superheated vapor expansion within said liquid ambient medium.
2. A method, comprising:
inserting a fiber optic into the vasculature to a point near an occlusion, wherein said fiber optic comprises a proximal end and a distal end; and coupling laser light into said proximal end, wherein said laser light has (i) a pulse frequency within the range of 10 Hz to 100 kHz, (ii) a wavelength within the range of 200 nm to 5000 nm and (iii) an energy density within the range of 0.01 J/cm2 to 4 J/cm2, wherein said laser light emerges from said distal end to generate an acoustic radiation field in a liquid ambient medium.
3. The method of claim 2, wherein said laser light has a pulse frequency within the range of > 1 kHz to 25 kHz.
4. The method of claim 3, wherein said laser light has a pulse duration of less than 200 ns, wherein said laser light that emerges from said distal end generates said acoustic radiation field through thermoelastic expansion of said liquid ambient medium.
5. The method of claim 3, wherein said laser light that emerges from said distal end generates an acoustic radiation field through superheated vapor expansion.
6. The method of claim 3, wherein said laser light emerges from said distal end to generate an acoustic radiation field in a liquid ambient medium for the removal of an intravascular occlusion in said vasculature.
7. The method of claim 6, wherein said intravascular occlusion is selected from a group consisting of atherosclerotic plaque and thrombus.
8. The method of claim 3, wherein said liquid ambient medium is selected from a group consisting of blood, a biological saline solution, a biological saline solution containing an absorbing dye, a thrombolytic pharmaceutical and thrombus.
9. The method of claim 3, wherein said fiber optic is located within a catheter, said method further comprising injecting through said catheter into said liquid ambient medium a thrombolytic drug to emulsify said occlusion.
10. The method of claim 9, wherein a working channel runs parallel to said fiber optic within said catheter, wherein the step of injecting through said catheter into said liquid ambient medium a thrombolytic drug to emulsify said occlusion includes injecting through said working channel within said catheter said thrombolytic drug to emulsify said occlusion.
11. The method of claim 3, wherein said fiber optic is located within a catheter, said method further comprising injecting through said catheter into said liquid ambient medium a radiographic contrast agent to facilitate visualization.
12. The method of claim 3, further comprising monitoring and controlling the magnitude of the acoustic vibrations induced in the tissue through a feedback mechanism.
13. The method of claim 3, wherein said step of inserting a fiber optic into the vasculature includes inserting a fiber optic having a tip selected from a group consisting of a concave tip, a convex tip and a planar tip.
14. The method of claim 3, wherein said step of inserting a fiber optic into the vasculature includes inserting a fiber optic having variable diameter fiber optic into said vasculature.
15. The method of claim 3, wherein said step of inserting a fiber optic into the vasculature includes inserting a fiber optic comprising a composite of glass and plastic into said vasculature.
16. The method of claim 3, wherein said laser light emerges from said distal end to generate, through a mechanism selected from a group consisting of thermoelastic, thermodynamic and a combination of thermoelastic and thermodynamic mechanisms, an acoustic radiation field in a liquid ambient medium for the removal of an intravascular occlusion in said blood vessel.
17. The method of claim 3, wherein said laser light emerges from said distal end to generate an acoustic radiation field in a liquid ambient medium for the removal of an intravascular occlusion in said blood vessel, wherein said laser light has a pulse duration of less than 200 ns, wherein said laser light that emerges from said distal end generates an acoustic radiation field through thermoelastic expansion of said liquid ambient medium, wherein said laser light provides a controlled level of energy in said liquid ambient medium which creates a large thermoelastic stress in a small volume of said liquid ambient medium, wherein said volume of said liquid ambient medium that is heated by said laser light is determined by the absorption depth of said laser light in said liquid ambient medium, and wherein said absorption depth is controlled to produce a desired thermoelastic stress in said volume.
18. The method of claim 3, wherein said laser light emerges from said distal end to generate an acoustic radiation field in a liquid ambient medium for the removal of an intravascular occlusion in said blood vessel, wherein said laser light has a pulse duration that is short enough to deposit all of the laser energy into the absorbing fluid in a time scale shorter than the acoustic transit time across the smallest dimension of absorbing region, wherein said laser light that emerges from said distal end generates an acoustic radiation field through thermoelastic expansion of said liquid ambient medium.
19. The method of claim 3, wherein said fiber optic comprises a bundle of fiber strands, wherein said laser light is coupled into said proximal end at varying times, wherein said laser light within individual strands of said bundle arrives at said distal end at different times, wherein said different times are adjusted to control the directionality and shape of said acoustic radiation field, wherein said different times are adjusted in combination with the different spatial positions of said individual strands.
20. The method of claim 3, wherein said laser light is used as a signal source for producing acoustic images of structures in body tissues.
21. A method for producing an ultrasonic radiation field through thermoelastic expansion of a liquid ambient medium located within vasculature, comprising:
inserting a fiber optic into said vasculature;
depositing laser energy in a volume of said liquid ambient medium comparable to the diameter of said fiber optic, in a time scale of duration less than the acoustic transit time across the length of said volume;
controlling said laser energy such that the maximum size of a cavitation bubble is approximately the same as the fiber diameter;
and pulsing said laser energy at a repetition rate such that multiple cycles of this process generates an acoustic radiation field in the surrounding fluid.
22. The method of claim 20, further comprising synchronizing the laser pulse repetition rate of said laser energy with the cavity lifetime to achieve resonant operation.
23. A method for producing an ultrasonic radiation field through vapor expansion of a liquid ambient medium located within vasculature, comprising:

inserting a fiber optic into said vasculature;
depositing laser energy in a small volume of said liquid ambient medium to produce a cavitation bubble;
controlling said laser energy such that the maximum size of said cavitation bubble is approximately the same as the diameter of said fiber diameter; and pulsing said laser energy at a repetition rate such that multiple cycles of the generation of said cavitation bubble and the collapse thereof generates an acoustic radiation field in said liquid ambient medium.
24. The method of claim 23, further comprising the step of matching the pulse period of said laser energy to the cavitation lifetime of said cavitation bubble to achieve resonant operation.
25. An apparatus, comprising:
a fiber optic for insertion into the vasculature to a point near an occlusion, wherein said fiber optic comprises a proximal end and a distal end; and a laser to provide laser light for coupling into said proximal end, wherein said laser light has (i) a pulse frequency within the range of 10 Hz and 100 kHz, (ii) a wavelength within the range of 200 nm and 5000 nm and (iii) an energy density within the range of 0.01 J/cm2 to J/cm2, wherein said laser light emerges from said distal end to generate an acoustic radiation field in a liquid ambient medium.
26. The apparatus of claim 25, wherein said laser light has a pulse frequency within the range of > 1 kHz to 25 kHz.
27. The apparatus of claim 26, wherein said laser light has a pulse duration of less than 200 ns, wherein said laser light that emerges from said distal end generates said acoustic radiation field through thermoelastic expansion of said liquid ambient medium.
28. The apparatus of claim 26, wherein said laser light that emerges from said distal end generates said acoustic radiation field through superheated vapor expansion.
29. The apparatus of claim 26, wherein said laser light emerges from said distal end to generate an acoustic radiation field in a liquid ambient medium for the removal of an intravascular occlusion in said vasculatur.
30. The apparatus of claim 29, wherein said intravascular occlusion is selected from a group consisting of atherosclerotic plaque and thrombus.
31. The apparatus of claim 25, wherein said liquid ambient medium is selected from a group consisting of blood, a biological saline solution, a biological saline solution containing an absorbing dye, a thrombolytic pharmaceutical and thrombus.
32. The apparatus of claim 25, further comprising a catheter, wherein said fiber optic is located within said catheter, wherein a thrombolytic drug may be injected through said catheter into said liquid ambient medium to emulsify said occlusion.
33. The apparatus of claim 32, further comprising a working channel that runs parallel to said fiber optic within said catheter, wherein said thrombolytic drug may be injected through said working channel to emulsify said occlusion.
34. The apparatus of claim 25, further comprising a catheter, wherein said fiber optic is located within a catheter, wherein a radiographic contrast agent may be injected through said catheter into said liquid ambient medium to facilitate visualization.
35. The apparatus of claim 25, further comprising means for monitoring and controlling the magnitude of said acoustic radiation field induced in said liquid ambient medium.
36. The apparatus of claim 25, wherein said fiber optic comprises a tip having a shape that is selected from a group consisting of concave, convex and planar.
37. The apparatus of claim 25, wherein said fiber optic comprises a variable diameter.
38. The apparatus of claim 37, wherein said fiber optic comprises a variable diameter that is tapered at the tip of said fiber optic.
39. The apparatus of claim 25, wherein said fiber optic comprises a composite of glass and plastic.
40. The apparatus of claim 39, wherein said fiber optic comprises a composite of glass and a short section of plastic at the tip of said fiber optic, wherein said short section has a length within the range of 3 mm to 3 cm.
41. The apparatus of claim 25, wherein the volume of said liquid ambient medium that is heated by said laser light is determined by the absorption depth of said laser light in said liquid ambient medium, and wherein said absorption depth is controlled to produce a desired thermoelastic stress in said volume.
42. The apparatus of claim 25, wherein said laser light has a pulse duration that is short enough to deposit all of the laser energy into the absorbing fluid in a time scale shorter than the acoustic transit time across the smallest dimension of the absorbing region, wherein said laser light that emerges from said distal end generates an acoustic radiation field through thermoelastic expansion of said liquid ambient medium.
43. The apparatus of claim 25, wherein said fiber optic comprises a tip configured for use as an optical element to focus the light energy in said liquid ambient medium, wherein said tip is further configured to optimize the beam profile of said laser energy for generation of a desired acoustic energy.
44. The apparatus of claim 25, wherein said fiber optic comprises a tip having a surface that is prepared by a process selected from a group consisting of grinding, polishing and chemically etching.
45. The apparatus of claim 25, wherein said laser comprises a tunable wavelength.
46. A apparatus for producing an ultrasonic radiation field through thermoelastic expansion of a liquid ambient medium located within vasculature, comprising:
a fiber optic for insertion into said vasculature;
means for depositing laser energy in a volume of said liquid ambient medium, wherein said volume is comparable to the diameter of said fiber optic, wherein said laser energy is deposited in a time scale of duration less than the acoustic transit time across the length of said volume;
means for controlling said laser energy such that the maximum size of a cavitation bubble is approximately the same as the diameter of said fiber optic; and means for pulsing said laser energy at a repetition rate such that multiple cycles of this process generates an acoustic radiation field in the surrounding fluid.
47. The apparatus of claim 46, further comprising means for synchronizing the laser pulse repetition rate of said laser energy with the cavity lifetime.
48. A apparatus for producing an ultrasonic radiation field through vapor expansion of a liquid ambient medium located within vasculature, comprising:
a fiber optic for insertion into said vasculature;
means for depositing laser energy in a small volume of said liquid ambient medium to produce a cavitation bubble;
means for controlling said laser energy such that the maximum size of said cavitation bubble is approximately the same as the diameter of said fiber optic; and means for pulsing said laser energy at a repetition rate such that multiple cycles of the generation of said cavitation bubble and the collapse thereof generates an acoustic radiation field in said liquid ambient medium.
CA002252739A 1996-04-24 1997-04-23 Opto-acoustic thrombolysis Abandoned CA2252739A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/639,017 US6022309A (en) 1996-04-24 1996-04-24 Opto-acoustic thrombolysis
US08/639,017 1996-04-24

Publications (1)

Publication Number Publication Date
CA2252739A1 true CA2252739A1 (en) 1997-10-30

Family

ID=24562391

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002252739A Abandoned CA2252739A1 (en) 1996-04-24 1997-04-23 Opto-acoustic thrombolysis

Country Status (10)

Country Link
US (1) US6022309A (en)
EP (1) EP0959782B1 (en)
JP (1) JP2000508938A (en)
KR (1) KR20000010666A (en)
CN (1) CN1216910A (en)
AT (1) ATE274859T1 (en)
AU (1) AU725515B2 (en)
CA (1) CA2252739A1 (en)
DE (1) DE69730525D1 (en)
WO (1) WO1997039690A1 (en)

Families Citing this family (216)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6288499B1 (en) * 1997-06-12 2001-09-11 Biolase Technology, Inc. Electromagnetic energy distributions for electromagnetically induced mechanical cutting
US6231567B1 (en) * 1995-08-31 2001-05-15 Biolase Technology Inc. Material remover and method
US20100125291A1 (en) * 1995-08-31 2010-05-20 Rizoiu Ioana M Drill and flavored fluid particles combination
US6405069B1 (en) * 1996-01-31 2002-06-11 Board Of Regents, The University Of Texas System Time-resolved optoacoustic method and system for noninvasive monitoring of glucose
GB9712524D0 (en) * 1997-06-16 1997-08-20 Nycomed Imaging As Method
MXPA00003920A (en) * 1997-10-21 2002-08-06 Univ California Photoacoustic removal of occlusions from blood vessels.
US6368318B1 (en) 1998-01-23 2002-04-09 The Regents Of The University Of California Opto-acoustic recanilization delivery system
US6290668B1 (en) * 1998-04-30 2001-09-18 Kenton W. Gregory Light delivery catheter and methods for the use thereof
US6547779B2 (en) 1998-07-22 2003-04-15 Endovasix, Inc. Flexible flow apparatus and method for the disruption of occlusions
US6440124B1 (en) 1998-07-22 2002-08-27 Endovasix, Inc. Flexible flow apparatus and method for the disruption of occlusions
US6139543A (en) 1998-07-22 2000-10-31 Endovasix, Inc. Flow apparatus for the disruption of occlusions
US6210400B1 (en) 1998-07-22 2001-04-03 Endovasix, Inc. Flexible flow apparatus and method for the disruption of occlusions
US6855123B2 (en) 2002-08-02 2005-02-15 Flow Cardia, Inc. Therapeutic ultrasound system
US6484052B1 (en) * 1999-03-30 2002-11-19 The Regents Of The University Of California Optically generated ultrasound for enhanced drug delivery
US6539944B1 (en) * 1999-06-11 2003-04-01 Brant D. Watson Dethrombosis facilitated by vasodilation
US6443976B1 (en) * 1999-11-30 2002-09-03 Akorn, Inc. Methods for treating conditions and illnesses associated with abnormal vasculature
US8241274B2 (en) 2000-01-19 2012-08-14 Medtronic, Inc. Method for guiding a medical device
US8256430B2 (en) 2001-06-15 2012-09-04 Monteris Medical, Inc. Hyperthermia treatment and probe therefor
JP3868724B2 (en) * 2000-07-18 2007-01-17 独立行政法人科学技術振興機構 Ultrasound angioscope system
US20020133111A1 (en) * 2001-03-19 2002-09-19 Shadduck John H. Neuro-thrombectomy catheter and method of use
US6517531B2 (en) 2001-04-27 2003-02-11 Scimed Life Systems, Inc. Medical suction device
US7117134B2 (en) 2001-10-18 2006-10-03 Lockheed Martin Corporation Method to optimize generation of ultrasound using mathematical modeling for laser ultrasound inspection
AU2002359814A1 (en) * 2001-12-19 2003-07-09 Ran Yaron Miniature refrigeration system for cryothermal ablation catheter
EP1458301A1 (en) 2001-12-28 2004-09-22 The Spectranetics Corporation Method for treatment of vascular occlusions with inhibition of platelet aggregation
EP1665998A3 (en) 2002-01-08 2010-10-20 Bio Scan Ltd. Ultrasonic transducer probe
AU2003215119B2 (en) * 2002-02-11 2008-11-20 Gold-T Tech, Inc. Method for preventing thrombus formation
US8150519B2 (en) 2002-04-08 2012-04-03 Ardian, Inc. Methods and apparatus for bilateral renal neuromodulation
US7617005B2 (en) 2002-04-08 2009-11-10 Ardian, Inc. Methods and apparatus for thermally-induced renal neuromodulation
US20030236533A1 (en) * 2002-06-20 2003-12-25 The Regents Of The University Of California Shape memory polymer actuator and catheter
US9955994B2 (en) 2002-08-02 2018-05-01 Flowcardia, Inc. Ultrasound catheter having protective feature against breakage
US7335180B2 (en) 2003-11-24 2008-02-26 Flowcardia, Inc. Steerable ultrasound catheter
US7220233B2 (en) 2003-04-08 2007-05-22 Flowcardia, Inc. Ultrasound catheter devices and methods
US6942677B2 (en) 2003-02-26 2005-09-13 Flowcardia, Inc. Ultrasound catheter apparatus
US7604608B2 (en) * 2003-01-14 2009-10-20 Flowcardia, Inc. Ultrasound catheter and methods for making and using same
US7137963B2 (en) 2002-08-26 2006-11-21 Flowcardia, Inc. Ultrasound catheter for disrupting blood vessel obstructions
US20070123776A1 (en) * 2003-04-09 2007-05-31 Rami Aharoni Ultrasonic probing device with distributed sensing elements
US20040260182A1 (en) * 2003-06-23 2004-12-23 Zuluaga Andres F. Intraluminal spectroscope with wall contacting probe
JP2007504910A (en) 2003-09-12 2007-03-08 ミノウ・メディカル・エルエルシイ Selectable biased reshaping and / or excision of atherosclerotic material
US20050059993A1 (en) * 2003-09-17 2005-03-17 Kamal Ramzipoor Embolectomy device
RU2372117C2 (en) * 2003-09-18 2009-11-10 Аркюо Медикал, Инк. Method of opto-thermo-mechanical impact onto biological tissue and device to this end
US7758510B2 (en) 2003-09-19 2010-07-20 Flowcardia, Inc. Connector for securing ultrasound catheter to transducer
US6949072B2 (en) * 2003-09-22 2005-09-27 Infraredx, Inc. Devices for vulnerable plaque detection
US7744604B2 (en) * 2003-11-13 2010-06-29 Lawrence Livermore National Security, Llc Shape memory polymer medical device
US7740626B2 (en) * 2003-11-21 2010-06-22 Terumo Kabushiki Kaisha Laser induced liquid jet generating apparatus
EP1541091A1 (en) * 2003-12-10 2005-06-15 EL.EN. S.p.A. Device for treating tumors by laser thermotherapy
US7198549B2 (en) * 2004-06-16 2007-04-03 Cabot Microelectronics Corporation Continuous contour polishing of a multi-material surface
US7540852B2 (en) 2004-08-26 2009-06-02 Flowcardia, Inc. Ultrasound catheter devices and methods
US8396548B2 (en) 2008-11-14 2013-03-12 Vessix Vascular, Inc. Selective drug delivery in a lumen
US9713730B2 (en) 2004-09-10 2017-07-25 Boston Scientific Scimed, Inc. Apparatus and method for treatment of in-stent restenosis
US8221343B2 (en) 2005-01-20 2012-07-17 Flowcardia, Inc. Vibrational catheter devices and methods for making same
US20060206028A1 (en) * 2005-03-11 2006-09-14 Qi Yu Apparatus and method for ablating deposits from blood vessel
US7645290B2 (en) * 2005-05-05 2010-01-12 Lucas Paul R Multi-functional thrombectomy device
US8057408B2 (en) 2005-09-22 2011-11-15 The Regents Of The University Of Michigan Pulsed cavitational ultrasound therapy
US10219815B2 (en) * 2005-09-22 2019-03-05 The Regents Of The University Of Michigan Histotripsy for thrombolysis
US20070083120A1 (en) * 2005-09-22 2007-04-12 Cain Charles A Pulsed cavitational ultrasound therapy
US7450241B2 (en) * 2005-09-30 2008-11-11 Infraredx, Inc. Detecting vulnerable plaque
JP4409499B2 (en) * 2005-10-25 2010-02-03 国立大学法人浜松医科大学 Thrombolysis device
US20080177220A1 (en) * 2006-01-06 2008-07-24 The Curators Of The University Of Missouri Ultrasound-Mediated Transcleral Drug Delivery
WO2007100937A2 (en) * 2006-01-19 2007-09-07 The Regents Of The University Of Michigan System and method for spectroscopic photoacoustic tomography
US20090306533A1 (en) * 2006-01-26 2009-12-10 Rousche Patrick J Stroke Inducing and Monitoring System and Method for Using the Same
CA2638012A1 (en) * 2006-02-02 2007-08-09 Releaf Medical Ltd. Shock-wave generating device, such as for the treatment of calcific aortic stenosis
US9282984B2 (en) * 2006-04-05 2016-03-15 Flowcardia, Inc. Therapeutic ultrasound system
AU2007240780B2 (en) 2006-04-20 2014-01-16 Sonendo, Inc. Apparatus and methods for treating root canals of teeth
US7993303B2 (en) 2006-04-21 2011-08-09 Abbott Laboratories Stiffening support catheter and methods for using the same
US8206370B2 (en) * 2006-04-21 2012-06-26 Abbott Laboratories Dual lumen guidewire support catheter
US20070250149A1 (en) * 2006-04-21 2007-10-25 Abbott Laboratories Stiffening Support Catheters and Methods for Using the Same
US20080065014A1 (en) * 2006-04-21 2008-03-13 Abbott Laboratories Systems, Methods, and Devices to Facilitate Wire and Device Crossings of Obstructions in Body Lumens
US8246574B2 (en) * 2006-04-21 2012-08-21 Abbott Laboratories Support catheter
US7927305B2 (en) * 2006-04-21 2011-04-19 Abbott Laboratories Systems, methods, and devices for injecting media contrast
WO2007127339A2 (en) * 2006-04-26 2007-11-08 Tyco Healthcare Group Lp Multi-stage microporation device
US8019435B2 (en) 2006-05-02 2011-09-13 Boston Scientific Scimed, Inc. Control of arterial smooth muscle tone
US20080039746A1 (en) 2006-05-25 2008-02-14 Medtronic, Inc. Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions
JP2008036153A (en) 2006-08-07 2008-02-21 Hamamatsu Photonics Kk Light irradiation apparatus
US7980854B2 (en) 2006-08-24 2011-07-19 Medical Dental Advanced Technologies Group, L.L.C. Dental and medical treatments and procedures
EP2954868A1 (en) 2006-10-18 2015-12-16 Vessix Vascular, Inc. Tuned rf energy and electrical tissue characterization for selective treatment of target tissues
WO2008049082A2 (en) 2006-10-18 2008-04-24 Minnow Medical, Inc. Inducing desirable temperature effects on body tissue
AU2007310991B2 (en) 2006-10-18 2013-06-20 Boston Scientific Scimed, Inc. System for inducing desirable temperature effects on body tissue
US8448644B2 (en) * 2006-11-02 2013-05-28 Cooltouch Incorporated Sonic endovenous catheter
US8246643B2 (en) 2006-11-07 2012-08-21 Flowcardia, Inc. Ultrasound catheter having improved distal end
WO2008067438A2 (en) * 2006-11-29 2008-06-05 The Regents Of University Of Michigan System and method for photoacoustic guided diffuse optical imaging
US20080173093A1 (en) * 2007-01-18 2008-07-24 The Regents Of The University Of Michigan System and method for photoacoustic tomography of joints
US20080221647A1 (en) * 2007-02-23 2008-09-11 The Regents Of The University Of Michigan System and method for monitoring photodynamic therapy
WO2009020994A2 (en) * 2007-08-06 2009-02-12 Doheny Eye Institute Ultrasound and microbubbles in ocular diagnostics and therapies
US8728092B2 (en) * 2008-08-14 2014-05-20 Monteris Medical Corporation Stereotactic drive system
US8747418B2 (en) * 2008-08-15 2014-06-10 Monteris Medical Corporation Trajectory guide
CN102271603A (en) 2008-11-17 2011-12-07 明诺医学股份有限公司 Selective accumulation of energy with or without knowledge of tissue topography
US8226566B2 (en) 2009-06-12 2012-07-24 Flowcardia, Inc. Device and method for vascular re-entry
AU2010284313B2 (en) 2009-08-17 2016-01-28 Histosonics, Inc. Disposable acoustic coupling medium container
EP2470087B1 (en) * 2009-08-26 2015-03-25 The Regents Of The University Of Michigan Devices for using controlled bubble cloud cavitation in fractionating urinary stones
WO2011028603A2 (en) 2009-08-26 2011-03-10 The Regents Of The University Of Michigan Micromanipulator control arm for therapeutic and imaging ultrasound transducers
US8539813B2 (en) 2009-09-22 2013-09-24 The Regents Of The University Of Michigan Gel phantoms for testing cavitational ultrasound (histotripsy) transducers
ATE533427T1 (en) * 2009-12-10 2011-12-15 W & H Dentalwerk Buermoos Gmbh MEDICAL, IN PARTICULAR DENTAL, TREATMENT DEVICE FOR DELIVERING A MEDIUM
EP2555699B1 (en) 2010-04-09 2019-04-03 Vessix Vascular, Inc. Power generating and control apparatus for the treatment of tissue
US9192790B2 (en) 2010-04-14 2015-11-24 Boston Scientific Scimed, Inc. Focused ultrasonic renal denervation
US8473067B2 (en) 2010-06-11 2013-06-25 Boston Scientific Scimed, Inc. Renal denervation and stimulation employing wireless vascular energy transfer arrangement
US9084609B2 (en) 2010-07-30 2015-07-21 Boston Scientific Scime, Inc. Spiral balloon catheter for renal nerve ablation
US9358365B2 (en) 2010-07-30 2016-06-07 Boston Scientific Scimed, Inc. Precision electrode movement control for renal nerve ablation
US9408661B2 (en) 2010-07-30 2016-08-09 Patrick A. Haverkost RF electrodes on multiple flexible wires for renal nerve ablation
US9155589B2 (en) 2010-07-30 2015-10-13 Boston Scientific Scimed, Inc. Sequential activation RF electrode set for renal nerve ablation
US9463062B2 (en) 2010-07-30 2016-10-11 Boston Scientific Scimed, Inc. Cooled conductive balloon RF catheter for renal nerve ablation
US8974451B2 (en) 2010-10-25 2015-03-10 Boston Scientific Scimed, Inc. Renal nerve ablation using conductive fluid jet and RF energy
US9220558B2 (en) 2010-10-27 2015-12-29 Boston Scientific Scimed, Inc. RF renal denervation catheter with multiple independent electrodes
US9028485B2 (en) 2010-11-15 2015-05-12 Boston Scientific Scimed, Inc. Self-expanding cooling electrode for renal nerve ablation
US9089350B2 (en) 2010-11-16 2015-07-28 Boston Scientific Scimed, Inc. Renal denervation catheter with RF electrode and integral contrast dye injection arrangement
US9668811B2 (en) 2010-11-16 2017-06-06 Boston Scientific Scimed, Inc. Minimally invasive access for renal nerve ablation
US9326751B2 (en) 2010-11-17 2016-05-03 Boston Scientific Scimed, Inc. Catheter guidance of external energy for renal denervation
US9060761B2 (en) 2010-11-18 2015-06-23 Boston Scientific Scime, Inc. Catheter-focused magnetic field induced renal nerve ablation
US9192435B2 (en) 2010-11-22 2015-11-24 Boston Scientific Scimed, Inc. Renal denervation catheter with cooled RF electrode
US9023034B2 (en) 2010-11-22 2015-05-05 Boston Scientific Scimed, Inc. Renal ablation electrode with force-activatable conduction apparatus
US20120157993A1 (en) 2010-12-15 2012-06-21 Jenson Mark L Bipolar Off-Wall Electrode Device for Renal Nerve Ablation
US9220561B2 (en) 2011-01-19 2015-12-29 Boston Scientific Scimed, Inc. Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury
US9125677B2 (en) 2011-01-22 2015-09-08 Arcuo Medical, Inc. Diagnostic and feedback control system for efficacy and safety of laser application for tissue reshaping and regeneration
AU2012283908B2 (en) 2011-07-20 2017-02-16 Boston Scientific Scimed, Inc. Percutaneous devices and methods to visualize, target and ablate nerves
AU2012287189B2 (en) 2011-07-22 2016-10-06 Boston Scientific Scimed, Inc. Nerve modulation system with a nerve modulation element positionable in a helical guide
US9144694B2 (en) 2011-08-10 2015-09-29 The Regents Of The University Of Michigan Lesion generation through bone using histotripsy therapy without aberration correction
US9186210B2 (en) 2011-10-10 2015-11-17 Boston Scientific Scimed, Inc. Medical devices including ablation electrodes
US9420955B2 (en) 2011-10-11 2016-08-23 Boston Scientific Scimed, Inc. Intravascular temperature monitoring system and method
WO2013055815A1 (en) 2011-10-11 2013-04-18 Boston Scientific Scimed, Inc. Off -wall electrode device for nerve modulation
US9364284B2 (en) 2011-10-12 2016-06-14 Boston Scientific Scimed, Inc. Method of making an off-wall spacer cage
WO2013056125A2 (en) 2011-10-14 2013-04-18 RA Medical Systems Small flexible liquid core catheter for laser ablation in body lumens and methods for use
EP2768563B1 (en) 2011-10-18 2016-11-09 Boston Scientific Scimed, Inc. Deflectable medical devices
EP2768568B1 (en) 2011-10-18 2020-05-06 Boston Scientific Scimed, Inc. Integrated crossing balloon catheter
CN104023662B (en) 2011-11-08 2018-02-09 波士顿科学西美德公司 Hole portion renal nerve melts
US9119600B2 (en) 2011-11-15 2015-09-01 Boston Scientific Scimed, Inc. Device and methods for renal nerve modulation monitoring
US9119632B2 (en) 2011-11-21 2015-09-01 Boston Scientific Scimed, Inc. Deflectable renal nerve ablation catheter
CN102500006B (en) * 2011-11-22 2017-03-29 周相真 A kind of armarium for treating blood associated diseases
CN102512206B (en) * 2011-12-13 2014-04-09 苏州生物医学工程技术研究所 Intravenous ultrasound-based ultrasonic diagnosis and photoacoustic therapy device and therapeutic method thereof
US9265969B2 (en) 2011-12-21 2016-02-23 Cardiac Pacemakers, Inc. Methods for modulating cell function
EP3138521B1 (en) 2011-12-23 2019-05-29 Vessix Vascular, Inc. Apparatuses for remodeling tissue of or adjacent to a body passage
US9433760B2 (en) 2011-12-28 2016-09-06 Boston Scientific Scimed, Inc. Device and methods for nerve modulation using a novel ablation catheter with polymeric ablative elements
US9050106B2 (en) 2011-12-29 2015-06-09 Boston Scientific Scimed, Inc. Off-wall electrode device and methods for nerve modulation
WO2013109269A1 (en) 2012-01-18 2013-07-25 Bard Peripheral Vascular, Inc. Vascular re-entry device
CN110623765A (en) 2012-03-22 2019-12-31 索南多股份有限公司 Apparatus and method for cleaning teeth
US9049783B2 (en) 2012-04-13 2015-06-02 Histosonics, Inc. Systems and methods for obtaining large creepage isolation on printed circuit boards
EP2844343B1 (en) 2012-04-30 2018-11-21 The Regents Of The University Of Michigan Ultrasound transducer manufacturing using rapid-prototyping method
WO2013169927A1 (en) 2012-05-08 2013-11-14 Boston Scientific Scimed, Inc. Renal nerve modulation devices
CN108113762A (en) 2012-06-27 2018-06-05 曼特瑞斯医药有限责任公司 The image guided therapy of tissue
CN103565493B (en) * 2012-07-26 2015-08-12 纳米新能源(唐山)有限责任公司 Nanoscale ultrasonic vibrator
JP6293145B2 (en) 2012-08-02 2018-03-14 バード・ペリフェラル・バスキュラー・インコーポレーテッド Ultrasound catheter system
US20140073907A1 (en) 2012-09-12 2014-03-13 Convergent Life Sciences, Inc. System and method for image guided medical procedures
WO2014032016A1 (en) 2012-08-24 2014-02-27 Boston Scientific Scimed, Inc. Intravascular catheter with a balloon comprising separate microporous regions
CN104780859B (en) 2012-09-17 2017-07-25 波士顿科学西美德公司 Self-positioning electrode system and method for renal regulation
WO2014047411A1 (en) 2012-09-21 2014-03-27 Boston Scientific Scimed, Inc. System for nerve modulation and innocuous thermal gradient nerve block
WO2014047454A2 (en) 2012-09-21 2014-03-27 Boston Scientific Scimed, Inc. Self-cooling ultrasound ablation catheter
EP2903688A4 (en) 2012-10-05 2016-06-15 Univ Michigan Bubble-induced color doppler feedback during histotripsy
US10835305B2 (en) 2012-10-10 2020-11-17 Boston Scientific Scimed, Inc. Renal nerve modulation devices and methods
WO2014081052A1 (en) * 2012-11-22 2014-05-30 한국과학기술원 Waste removing device for vascular and perivascular tissue using resonance frequency
EP3572036B1 (en) 2012-12-20 2021-05-26 Sonendo, Inc. Apparatus for cleaning teeth and root canals
WO2014163987A1 (en) 2013-03-11 2014-10-09 Boston Scientific Scimed, Inc. Medical devices for modulating nerves
US9693821B2 (en) 2013-03-11 2017-07-04 Boston Scientific Scimed, Inc. Medical devices for modulating nerves
US9808311B2 (en) 2013-03-13 2017-11-07 Boston Scientific Scimed, Inc. Deflectable medical devices
US9320530B2 (en) 2013-03-13 2016-04-26 The Spectranetics Corporation Assisted cutting balloon
US10201387B2 (en) 2013-03-13 2019-02-12 The Spectranetics Corporation Laser-induced fluid filled balloon catheter
US10842567B2 (en) 2013-03-13 2020-11-24 The Spectranetics Corporation Laser-induced fluid filled balloon catheter
AU2014237950B2 (en) 2013-03-15 2017-04-13 Boston Scientific Scimed, Inc. Control unit for use with electrode pads and a method for estimating an electrical leakage
US10265122B2 (en) 2013-03-15 2019-04-23 Boston Scientific Scimed, Inc. Nerve ablation devices and related methods of use
JP6220044B2 (en) 2013-03-15 2017-10-25 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Medical device for renal nerve ablation
CN103284774B (en) * 2013-05-22 2015-08-26 刘凤永 A kind of jet except pin device and application thereof
WO2014205399A1 (en) 2013-06-21 2014-12-24 Boston Scientific Scimed, Inc. Medical devices for renal nerve ablation having rotatable shafts
WO2014205388A1 (en) 2013-06-21 2014-12-24 Boston Scientific Scimed, Inc. Renal denervation balloon catheter with ride along electrode support
US9707036B2 (en) 2013-06-25 2017-07-18 Boston Scientific Scimed, Inc. Devices and methods for nerve modulation using localized indifferent electrodes
CA2911415A1 (en) 2013-06-26 2014-12-31 Sonendo, Inc. Apparatus and methods for filling teeth and root canals
EP3016605B1 (en) 2013-07-01 2019-06-05 Boston Scientific Scimed, Inc. Medical devices for renal nerve ablation
BR112015032926B1 (en) 2013-07-03 2022-04-05 Histosonics, Inc. ULTRASOUND THERAPY SYSTEM
US11432900B2 (en) 2013-07-03 2022-09-06 Histosonics, Inc. Articulating arm limiter for cavitational ultrasound therapy system
CN105377170A (en) 2013-07-11 2016-03-02 波士顿科学国际有限公司 Medical device with stretchable electrode assemblies
US10660698B2 (en) 2013-07-11 2020-05-26 Boston Scientific Scimed, Inc. Devices and methods for nerve modulation
CN105682594B (en) 2013-07-19 2018-06-22 波士顿科学国际有限公司 Helical bipolar electrodes renal denervation dominates air bag
WO2015013301A1 (en) 2013-07-22 2015-01-29 Boston Scientific Scimed, Inc. Renal nerve ablation catheter having twist balloon
WO2015013205A1 (en) 2013-07-22 2015-01-29 Boston Scientific Scimed, Inc. Medical devices for renal nerve ablation
EP4049605A1 (en) 2013-08-22 2022-08-31 Boston Scientific Scimed Inc. Flexible circuit having improved adhesion to a renal nerve modulation balloon
WO2015027164A1 (en) 2013-08-22 2015-02-26 The Regents Of The University Of Michigan Histotripsy using very short ultrasound pulses
CN105555218B (en) 2013-09-04 2019-01-15 波士顿科学国际有限公司 With radio frequency (RF) foley's tube rinsed with cooling capacity
CN105530885B (en) 2013-09-13 2020-09-22 波士顿科学国际有限公司 Ablation balloon with vapor deposited covering
US9687166B2 (en) 2013-10-14 2017-06-27 Boston Scientific Scimed, Inc. High resolution cardiac mapping electrode array catheter
US11246654B2 (en) 2013-10-14 2022-02-15 Boston Scientific Scimed, Inc. Flexible renal nerve ablation devices and related methods of use and manufacture
US9770606B2 (en) 2013-10-15 2017-09-26 Boston Scientific Scimed, Inc. Ultrasound ablation catheter with cooling infusion and centering basket
CN105636537B (en) 2013-10-15 2018-08-17 波士顿科学国际有限公司 Medical instrument sacculus
US9962527B2 (en) * 2013-10-16 2018-05-08 Ra Medical Systems, Inc. Methods and devices for treatment of stenosis of arteriovenous fistula shunts
EP3057521B1 (en) 2013-10-18 2020-03-25 Boston Scientific Scimed, Inc. Balloon catheters with flexible conducting wires
US10271898B2 (en) 2013-10-25 2019-04-30 Boston Scientific Scimed, Inc. Embedded thermocouple in denervation flex circuit
JP2017502715A (en) * 2013-11-18 2017-01-26 コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. Thrombus dispersion method and apparatus
CN103706047A (en) * 2013-12-17 2014-04-09 南京航空航天大学 Ultrasonic-based thrombolytic drug treatment method
CN105899157B (en) 2014-01-06 2019-08-09 波士顿科学国际有限公司 Tear-proof flexible circuit assembly
US11000679B2 (en) 2014-02-04 2021-05-11 Boston Scientific Scimed, Inc. Balloon protection and rewrapping devices and related methods of use
CN106572881B (en) 2014-02-04 2019-07-26 波士顿科学国际有限公司 Substitution of the heat sensor on bipolar electrode is placed
WO2015143025A1 (en) 2014-03-18 2015-09-24 Monteris Medical Corporation Image-guided therapy of a tissue
US9504484B2 (en) 2014-03-18 2016-11-29 Monteris Medical Corporation Image-guided therapy of a tissue
US10675113B2 (en) 2014-03-18 2020-06-09 Monteris Medical Corporation Automated therapy of a three-dimensional tissue region
US11246659B2 (en) 2014-08-25 2022-02-15 The Spectranetics Corporation Liquid laser-induced pressure wave emitting catheter sheath
US10850078B2 (en) 2014-12-30 2020-12-01 The Spectranetics Corporation Electrically-induced fluid filled balloon catheter
WO2016109739A1 (en) 2014-12-30 2016-07-07 The Spectranetics Corporation Electrically-induced pressure wave emitting catheter sheath
US11058492B2 (en) 2014-12-30 2021-07-13 The Spectranetics Corporation Laser-induced pressure wave emitting catheter sheath
US10327830B2 (en) 2015-04-01 2019-06-25 Monteris Medical Corporation Cryotherapy, thermal therapy, temperature modulation therapy, and probe apparatus therefor
ES2948135T3 (en) 2015-06-24 2023-08-31 Univ Michigan Regents Histotripsy therapy systems for the treatment of brain tissue
US10555772B2 (en) 2015-11-23 2020-02-11 Ra Medical Systems, Inc. Laser ablation catheters having expanded distal tip windows for efficient tissue ablation
JP6804916B2 (en) 2016-09-27 2020-12-23 浜松ホトニクス株式会社 Monitor device and how to operate the monitor device
US11730979B2 (en) 2016-10-05 2023-08-22 Board Of Regents, The University Of Texas System Nanopulse light therapy
US20180140321A1 (en) 2016-11-23 2018-05-24 C. R. Bard, Inc. Catheter With Retractable Sheath And Methods Thereof
US11596726B2 (en) 2016-12-17 2023-03-07 C.R. Bard, Inc. Ultrasound devices for removing clots from catheters and related methods
US10758256B2 (en) 2016-12-22 2020-09-01 C. R. Bard, Inc. Ultrasonic endovascular catheter
US10582983B2 (en) 2017-02-06 2020-03-10 C. R. Bard, Inc. Ultrasonic endovascular catheter with a controllable sheath
US10470748B2 (en) 2017-04-03 2019-11-12 C. R. Bard, Inc. Ultrasonic endovascular catheter with expandable portion
US10765440B2 (en) 2017-11-14 2020-09-08 Sonic Vascular, Inc. Focused intraluminal lithectomy catheter device and methods
CA3084914A1 (en) * 2017-12-08 2019-06-13 Les Solutions Medicales Soundbite Inc. Combined non-invasive and minimally-invasive mechanical energy targeting
CN108187183B (en) * 2017-12-22 2020-12-18 中国船舶重工集团公司第七一五研究所 Built-in medical ultrasonic thrombolysis therapeutic apparatus
JP2019166289A (en) 2018-03-22 2019-10-03 ラ メディカル システムズ, インコーポレイテッド Liquid filled ablation catheter with overjacket
US20190290305A1 (en) * 2018-03-22 2019-09-26 Acoustic Wave Cell Therapy, Inc. Acoustic Shockwave Apparatus and Method
WO2020113083A1 (en) 2018-11-28 2020-06-04 Histosonics, Inc. Histotripsy systems and methods
CN114599300A (en) * 2019-11-12 2022-06-07 奥林巴斯株式会社 Laser crushing device, laser crushing system and laser crushing method
AU2021213168A1 (en) 2020-01-28 2022-09-01 The Regents Of The University Of Michigan Systems and methods for histotripsy immunosensitization
WO2021234811A1 (en) * 2020-05-19 2021-11-25 オリンパス株式会社 Laser light irradiation system and laser light irradiation method
EP4171419A1 (en) * 2020-06-30 2023-05-03 Koninklijke Philips N.V. Systems for laser catheter treatment in a vessel lumen
USD997355S1 (en) 2020-10-07 2023-08-29 Sonendo, Inc. Dental treatment instrument
CN112842522A (en) * 2021-01-27 2021-05-28 北京航空航天大学 Intravascular optical coherence tomography laser ablation catheter
CN114734139B (en) * 2022-05-17 2023-11-10 江苏大学 Laser cavitation micro-molding device suitable for inner wall member and processing method thereof

Family Cites Families (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3565062A (en) * 1968-06-13 1971-02-23 Ultrasonic Systems Ultrasonic method and apparatus for removing cholesterol and other deposits from blood vessels and the like
US3884236A (en) * 1971-10-28 1975-05-20 Mikhail M Krasnov Method of glaucoma treatment
US3866599A (en) * 1972-01-21 1975-02-18 Univ Washington Fiberoptic catheter
US3858577A (en) * 1974-04-05 1975-01-07 Univ Southern California Fiber optic laser light delivery system
US4204528A (en) * 1977-03-10 1980-05-27 Zafmedico Corp. Method and apparatus for fiber-optic intravascular endoscopy
US4207874A (en) * 1978-03-27 1980-06-17 Choy Daniel S J Laser tunnelling device
FR2442622A1 (en) * 1978-06-08 1980-06-27 Aron Rosa Daniele OPHTHALMOLOGICAL SURGERY APPARATUS
JPS5777936A (en) * 1980-11-01 1982-05-15 Asahi Optical Co Ltd Safety device for detecting transmission fiber trouble
US4418688A (en) * 1981-07-06 1983-12-06 Laserscope, Inc. Microcatheter having directable laser and expandable walls
US4800876A (en) * 1981-12-11 1989-01-31 Fox Kenneth R Method of and apparatus for laser treatment of body lumens
US5041108A (en) * 1981-12-11 1991-08-20 Pillco Limited Partnership Method for laser treatment of body lumens
US4448188A (en) * 1982-02-18 1984-05-15 Laserscope, Inc. Method for providing an oxygen bearing liquid to a blood vessel for the performance of a medical procedure
US5370675A (en) * 1992-08-12 1994-12-06 Vidamed, Inc. Medical probe device and method
JPS60126171A (en) * 1983-12-09 1985-07-05 インタ−ナショナル ビジネス マシ−ンズ コ−ポレ−ション Laser catheter apparatus
US4686979A (en) * 1984-01-09 1987-08-18 The United States Of America As Represented By The United States Department Of Energy Excimer laser phototherapy for the dissolution of abnormal growth
US4627436A (en) * 1984-03-01 1986-12-09 Innoventions Biomedical Inc. Angioplasty catheter and method for use thereof
US4587972A (en) * 1984-07-16 1986-05-13 Morantte Jr Bernardo D Device for diagnostic and therapeutic intravascular intervention
US5188632A (en) * 1984-12-07 1993-02-23 Advanced Interventional Systems, Inc. Guidance and delivery system for high-energy pulsed laser light
AT380634B (en) * 1985-01-14 1986-06-25 Schmidt Kloiber Heinz DEVICE FOR DESTRUCTING URINARY CONCRETE
US4682594A (en) * 1985-03-11 1987-07-28 Mcm Laboratories, Inc. Probe-and-fire lasers
US4641650A (en) * 1985-03-11 1987-02-10 Mcm Laboratories, Inc. Probe-and-fire lasers
US5104392A (en) * 1985-03-22 1992-04-14 Massachusetts Institute Of Technology Laser spectro-optic imaging for diagnosis and treatment of diseased tissue
US4887600A (en) * 1986-04-22 1989-12-19 The General Hospital Corporation Use of lasers to break down objects
IL78567A (en) * 1985-04-24 1991-12-15 Candela Corp Laser apparatus for medical use
US4862886A (en) * 1985-05-08 1989-09-05 Summit Technology Inc. Laser angioplasty
US4775361A (en) * 1986-04-10 1988-10-04 The General Hospital Corporation Controlled removal of human stratum corneum by pulsed laser to enhance percutaneous transport
US4867141A (en) * 1986-06-18 1989-09-19 Olympus Optical Co., Ltd. Medical treatment apparatus utilizing ultrasonic wave
EP0268019A1 (en) * 1986-11-13 1988-05-25 Messerschmitt-Bölkow-Blohm Gesellschaft mit beschränkter Haftung Apparatus for disintegrating a fluid-suspended solid body
RU2050152C1 (en) * 1986-11-27 1995-12-20 Сумимото Бейклайт Компани Лимитед Ultrasonic surgical apparatus
US4785806A (en) * 1987-01-08 1988-11-22 Yale University Laser ablation process and apparatus
US4770653A (en) * 1987-06-25 1988-09-13 Medilase, Inc. Laser angioplasty
DE3733489A1 (en) * 1987-10-03 1989-04-20 Telemit Electronic Gmbh METHOD AND DEVICE FOR PROCESSING MATERIALS WITH THE AID OF A LASER
US4813930A (en) * 1987-10-13 1989-03-21 Dimed, Inc. Angioplasty guiding catheters and methods for performing angioplasty
US4788975B1 (en) * 1987-11-05 1999-03-02 Trimedyne Inc Control system and method for improved laser angioplasty
US4791926A (en) * 1987-11-10 1988-12-20 Baxter Travenol Laboratories, Inc. Method of controlling laser energy removal of plaque to prevent vessel wall damage
US5163421A (en) * 1988-01-22 1992-11-17 Angiosonics, Inc. In vivo ultrasonic system with angioplasty and ultrasonic contrast imaging
US4887605A (en) * 1988-02-18 1989-12-19 Angelsen Bjorn A J Laser catheter delivery system for controlled atheroma ablation combining laser angioplasty and intra-arterial ultrasonic imagining
US5026367A (en) * 1988-03-18 1991-06-25 Cardiovascular Laser Systems, Inc. Laser angioplasty catheter and a method for use thereof
JPH01308544A (en) * 1988-06-06 1989-12-13 Sumitomo Electric Ind Ltd Body cavity laser operation apparatus
DE3833993A1 (en) * 1988-10-06 1990-04-12 Messerschmitt Boelkow Blohm LIGHT GUIDE AND RADIATION DEVICE
US5269778A (en) * 1988-11-01 1993-12-14 Rink John L Variable pulse width laser and method of use
DE3842916C1 (en) * 1988-12-21 1990-02-01 Messerschmitt-Boelkow-Blohm Gmbh, 8012 Ottobrunn, De
WO1990007904A1 (en) * 1989-01-23 1990-07-26 Medilase, Incorporated Acoustic monitoring and controlling of laser angioplasty
US5246447A (en) * 1989-02-22 1993-09-21 Physical Sciences, Inc. Impact lithotripsy
ATE159647T1 (en) * 1989-07-31 1997-11-15 Israel Barken ULTRASONIC LASER SURGICAL DEVICE
US5005180A (en) * 1989-09-01 1991-04-02 Schneider (Usa) Inc. Laser catheter system
JP3046315B2 (en) * 1989-09-05 2000-05-29 株式会社エス・エル・ティ・ジャパン Laser irradiation equipment
US5109859A (en) * 1989-10-04 1992-05-05 Beth Israel Hospital Association Ultrasound guided laser angioplasty
US5069664A (en) * 1990-01-25 1991-12-03 Inter Therapy, Inc. Intravascular ultrasonic angioplasty probe
US5059200A (en) * 1990-04-06 1991-10-22 John Tulip Laser lithotripsy
US5399158A (en) * 1990-05-31 1995-03-21 The United States Of America As Represented By The Secretary Of The Army Method of lysing thrombi
US5197470A (en) * 1990-07-16 1993-03-30 Eastman Kodak Company Near infrared diagnostic method and instrument
CA2048120A1 (en) * 1990-08-06 1992-02-07 William J. Drasler Thrombectomy method and device
US5496306A (en) * 1990-09-21 1996-03-05 Light Age, Inc. Pulse stretched solid-state laser lithotripter
US5354324A (en) * 1990-10-18 1994-10-11 The General Hospital Corporation Laser induced platelet inhibition
US5304171A (en) * 1990-10-18 1994-04-19 Gregory Kenton W Catheter devices and methods for delivering
US5254112A (en) * 1990-10-29 1993-10-19 C. R. Bard, Inc. Device for use in laser angioplasty
US5324255A (en) * 1991-01-11 1994-06-28 Baxter International Inc. Angioplasty and ablative devices having onboard ultrasound components and devices and methods for utilizing ultrasound to treat or prevent vasopasm
US5304115A (en) * 1991-01-11 1994-04-19 Baxter International Inc. Ultrasonic angioplasty device incorporating improved transmission member and ablation probe
US5368558A (en) * 1991-01-11 1994-11-29 Baxter International Inc. Ultrasonic ablation catheter device having endoscopic component and method of using same
DE4105060A1 (en) * 1991-02-19 1992-08-20 Med Laserzentrum Luebeck Gmbh METHOD AND DEVICE FOR MONITORING THE MATERIAL PROCESSING BY MEANS OF PULSED LASER LIGHT
US5116227A (en) * 1991-03-01 1992-05-26 Endo Technic Corporation Process for cleaning and enlarging passages
DE4108146C2 (en) * 1991-03-13 1995-04-20 Hohla Kristian Device for removing material with laser light
DE4114492C2 (en) * 1991-05-03 1996-10-24 Baasel Carl Lasertech Method and device for material processing using a laser
US5254114A (en) * 1991-08-14 1993-10-19 Coherent, Inc. Medical laser delivery system with internally reflecting probe and method
EP0606390A4 (en) * 1991-10-03 1994-12-07 Gen Hospital Corp Apparatus and method for vasodilation.
WO1993007806A1 (en) * 1991-10-15 1993-04-29 Seton Health Care Foundation, Inc. Pathological tissue analysis and removal system
US5224942A (en) * 1992-01-27 1993-07-06 Alcon Surgical, Inc. Surgical method and apparatus utilizing laser energy for removing body tissue
US5234667A (en) * 1992-02-03 1993-08-10 The Scripps Research Institute Centrifuge tube for improved pellet retention
US5281212A (en) * 1992-02-18 1994-01-25 Angeion Corporation Laser catheter with monitor and dissolvable tip
US5380273A (en) * 1992-05-19 1995-01-10 Dubrul; Will R. Vibrating catheter
US5242454A (en) * 1992-06-12 1993-09-07 Omega Universal Technologies, Ltd. Method for diagnosis and shock wave lithotripsy of stones in the submaxillary and parotid glands
WO1995022283A1 (en) * 1992-10-26 1995-08-24 Ultrasonic Sensing & Monitoring Systems, Inc. Catheter using optical fibers to transmit laser and ultrasonic energy
US5397293A (en) * 1992-11-25 1995-03-14 Misonix, Inc. Ultrasonic device with sheath and transverse motion damping
US5350375A (en) * 1993-03-15 1994-09-27 Yale University Methods for laser induced fluorescence intensity feedback control during laser angioplasty
US5334207A (en) * 1993-03-25 1994-08-02 Allen E. Coles Laser angioplasty device with magnetic direction control
US5656186A (en) * 1994-04-08 1997-08-12 The Regents Of The University Of Michigan Method for controlling configuration of laser induced breakdown and ablation
US5395361A (en) * 1994-06-16 1995-03-07 Pillco Limited Partnership Expandable fiberoptic catheter and method of intraluminal laser transmission
US5586981A (en) * 1994-08-25 1996-12-24 Xin-Hua Hu Treatment of cutaneous vascular and pigmented lesions
DE4437578A1 (en) * 1994-10-20 1996-05-02 Medolas Ges Fuer Medizintechni Device for removing tissue material in intracorporeal hollow channels with a laser catheter
US5571151A (en) * 1994-10-25 1996-11-05 Gregory; Kenton W. Method for contemporaneous application of laser energy and localized pharmacologic therapy

Also Published As

Publication number Publication date
AU725515B2 (en) 2000-10-12
DE69730525D1 (en) 2004-10-07
EP0959782B1 (en) 2004-09-01
JP2000508938A (en) 2000-07-18
US6022309A (en) 2000-02-08
AU2991897A (en) 1997-11-12
KR20000010666A (en) 2000-02-25
ATE274859T1 (en) 2004-09-15
WO1997039690A1 (en) 1997-10-30
CN1216910A (en) 1999-05-19
EP0959782A1 (en) 1999-12-01

Similar Documents

Publication Publication Date Title
EP0959782B1 (en) Opto-acoustic thrombolysis
US20020045890A1 (en) Opto-acoustic thrombolysis
EP0902654B1 (en) Opto-acoustic transducer for medical applications
US6368318B1 (en) Opto-acoustic recanilization delivery system
US6508816B2 (en) Medical instrument working end creating very high pressure gradients
US6210404B1 (en) Microjoule electrical discharge catheter for thrombolysis in stroke patients
US4887600A (en) Use of lasers to break down objects
US6428531B1 (en) Photoacoustic removal of occlusions from blood vessels
Razvi et al. Intracorporeal lithotripsy with the holmium: YAG laser
US5071422A (en) Use of lasers to break down objects
KR101529367B1 (en) Laser induced vapor/plasma mediated medical procedures and device
EP1018952A1 (en) Bubble detection
JPH07502423A (en) Devices and methods for vasodilation
EP0220304B1 (en) Use of lasers to break down objects
Tominaga et al. Application of underwater shock wave and laser-induced liquid jet to neurosurgery
EP3197381B1 (en) Laser lithotripsy system
Celliers et al. Opto-acoustic thrombolysis
MXPA98008850A (en) Optoacust thrombolism
Benett et al. Opto-acoustic transducer for medical applications
Dawood Computational Study and Analysis of the Optical Fiber Tip Mechanical Damage Threats during Laser Surgical Operations
Elkabir et al. Energy sources in urology
Verdaasdonck et al. Ultrasonic needle system for transmyocardial revascularization: mechanism of action and efficacy compared with laser modalities

Legal Events

Date Code Title Description
FZDE Discontinued